Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.

Journal of the National Cancer Institute - 18 Oct 2006

Barry Elizabeth L R, Baron John A, Bhat Shubha, Grau Maria V, Burke Carol A, Sandler Robert S, Ahnen Dennis J, Haile Robert W, O'Brien Thomas G

Abstract excerpt

BACKGROUND: Previous research suggests that the G315A single-nucleotide polymorphism in the ornithine decarboxylase (ODC) gene may be a genetic marker for risk of colorectal neoplasia and may also modify the association of aspirin use with risk. METHODS: We tested these hypotheses among participants in the Aspirin/Folate Polyp Prevention Study who were randomly assigned to placebo or to aspirin treatment (81 or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenomatous Polyposis Coli
Share to Anticarcinogenic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aspirin

Share to Folic Acid

Share to Gastrointestinal Agents

Share to Ornithine Decarboxylase

Share to Racial Groups

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 17047198
DOI: 10.1093/jnci/djj398

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.PMID 17047198Read ↗

Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.Semantic proximity Read ↗

Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention.Semantic proximity Read ↗

Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients.Semantic proximity Read ↗

Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene.Semantic proximity Read ↗

A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma.Semantic proximity Read ↗

Ornithine decarboxylase G316A genotype and colorectal cancer risk.Semantic proximity Read ↗

Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.Semantic proximity Read ↗

Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.Semantic proximity Read ↗

Dietary polyamine intake and risk of colorectal adenomatous polyps.Semantic proximity Read ↗

Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention.Semantic proximity Read ↗

Genetic variation in the base excision repair pathway, environmental risk factors, and colorectal adenoma risk.Semantic proximity Read ↗

Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.